Limits...
An epidemiologic analysis of co-occurring alcohol and drug use and disorders: findings from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC).

Falk D, Yi HY, Hiller-Sturmhöfel S - Alcohol Res Health (2008)

Bottom Line: The prevalence of drug use, weekly drug use, and DUDs increased with increasing levels of alcohol consumption and the presence of AUDs.The proportion of people with AUDs who had a co-morbid DUD varied considerably by drug type.These findings have important implications for the development of prevention and intervention approaches.

View Article: PubMed Central - PubMed

Affiliation: Alcohol Epidemiologic Data System of the National Institute on Alcohol Abuse and Alcoholism, operated by CSR, Incorporated, Arlington, Virginia.

ABSTRACT
The 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) sought to determine the prevalence of alcohol use and alcohol use disorders (AUDs), other drug use and drug use disorders (DUDs), and co-use and co-morbidity in the general adult U.S. population. Findings indicate that 5.6 percent of U.S. adults used both alcohol and drugs in the past year and that 1.1 percent had a co-morbid AUD and DUD. Alcohol use prevalence peaked between the ages of 25 and 44 and declined thereafter. The prevalence of other drug use, co-use, AUDs, DUDs, and co-morbid disorders was highest between the ages of 18 and 24 and declined steadily thereafter. Women and men showed similar trends for alcohol use, drug use, and co-use. Among ethnic/racial groups evaluated, Whites displayed the highest rates of alcohol use and American Indians/Alaskan Natives the highest rates of drug use. For AUDs, DUDs, and co-morbid disorders, rates were highest among American Indians/Alaskan Natives. The prevalence of drug use, weekly drug use, and DUDs increased with increasing levels of alcohol consumption and the presence of AUDs. The proportion of people with AUDs who had a co-morbid DUD varied considerably by drug type. These findings have important implications for the development of prevention and intervention approaches.

Show MeSH

Related in: MedlinePlus

Prevalence (%) of any past-year alcohol use disorder (AUD), drug use disorder (DUD), and co-morbid disorders by age in the United States, 2001–2002 NESARC.NOTE: Data are drawn from Table 2.
© Copyright Policy - public-domain
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3860461&req=5

f2-arh-31-2-100: Prevalence (%) of any past-year alcohol use disorder (AUD), drug use disorder (DUD), and co-morbid disorders by age in the United States, 2001–2002 NESARC.NOTE: Data are drawn from Table 2.

Mentions: The prevalence of AUDs, DUDs, and co-morbid disorders decreased with age (figure 2), with the highest rates (about 18 percent) found among the youngest group and the lowest rates found among the oldest group.11 In terms of an absolute percentage decrease, the sharpest drop for all disorder categories occurred between the group of 18- to 24-year-old subjects and the group of 25- to 44-year-old subjects.


An epidemiologic analysis of co-occurring alcohol and drug use and disorders: findings from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC).

Falk D, Yi HY, Hiller-Sturmhöfel S - Alcohol Res Health (2008)

Prevalence (%) of any past-year alcohol use disorder (AUD), drug use disorder (DUD), and co-morbid disorders by age in the United States, 2001–2002 NESARC.NOTE: Data are drawn from Table 2.
© Copyright Policy - public-domain
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3860461&req=5

f2-arh-31-2-100: Prevalence (%) of any past-year alcohol use disorder (AUD), drug use disorder (DUD), and co-morbid disorders by age in the United States, 2001–2002 NESARC.NOTE: Data are drawn from Table 2.
Mentions: The prevalence of AUDs, DUDs, and co-morbid disorders decreased with age (figure 2), with the highest rates (about 18 percent) found among the youngest group and the lowest rates found among the oldest group.11 In terms of an absolute percentage decrease, the sharpest drop for all disorder categories occurred between the group of 18- to 24-year-old subjects and the group of 25- to 44-year-old subjects.

Bottom Line: The prevalence of drug use, weekly drug use, and DUDs increased with increasing levels of alcohol consumption and the presence of AUDs.The proportion of people with AUDs who had a co-morbid DUD varied considerably by drug type.These findings have important implications for the development of prevention and intervention approaches.

View Article: PubMed Central - PubMed

Affiliation: Alcohol Epidemiologic Data System of the National Institute on Alcohol Abuse and Alcoholism, operated by CSR, Incorporated, Arlington, Virginia.

ABSTRACT
The 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) sought to determine the prevalence of alcohol use and alcohol use disorders (AUDs), other drug use and drug use disorders (DUDs), and co-use and co-morbidity in the general adult U.S. population. Findings indicate that 5.6 percent of U.S. adults used both alcohol and drugs in the past year and that 1.1 percent had a co-morbid AUD and DUD. Alcohol use prevalence peaked between the ages of 25 and 44 and declined thereafter. The prevalence of other drug use, co-use, AUDs, DUDs, and co-morbid disorders was highest between the ages of 18 and 24 and declined steadily thereafter. Women and men showed similar trends for alcohol use, drug use, and co-use. Among ethnic/racial groups evaluated, Whites displayed the highest rates of alcohol use and American Indians/Alaskan Natives the highest rates of drug use. For AUDs, DUDs, and co-morbid disorders, rates were highest among American Indians/Alaskan Natives. The prevalence of drug use, weekly drug use, and DUDs increased with increasing levels of alcohol consumption and the presence of AUDs. The proportion of people with AUDs who had a co-morbid DUD varied considerably by drug type. These findings have important implications for the development of prevention and intervention approaches.

Show MeSH
Related in: MedlinePlus